Prescription Digital Therapeutics

Latest News

PDT Studies: The Positives, the Shortcomings — and Getting the Good Parts ‘Packaged Together’
PDT Studies: The Positives, the Shortcomings — and Getting the Good Parts ‘Packaged Together’

November 17th 2023

The corresponding author of a study published in Health Affairs of the research supporting 20 FDA-authorized prescription digital therapeutics (PDTs) sees some positives but also an overall lack of rigor and the need for at least one high-quality clinical trial for each PDT.

Why Study the Studies of PDTs?
Why Study the Studies of PDTs?

November 16th 2023

Studies Supporting PDTs Often Short on Rigor, Inclusivity, Research Finds
Studies Supporting PDTs Often Short on Rigor, Inclusivity, Research Finds

November 16th 2023

Payers Warm To Prescription Digital Therapeutics But Want Real-World Evidence, Pilot Projects and Alternative Payment Contracts, Survey Shows
Payers Warm To Prescription Digital Therapeutics But Want Real-World Evidence, Pilot Projects and Alternative Payment Contracts, Survey Shows

November 10th 2023

Internet-based CBT Helps MS Patients With Depression Become Less Depressed
Internet-based CBT Helps MS Patients With Depression Become Less Depressed

October 24th 2023

Video Interviews
Latest CME Events & Activities

More News

© 2023 MJH Life Sciences

All rights reserved.